Adage Capital Partners
STAA icon

Adage Capital Partners’s STAAR Surgical STAA Stock Holding History

Adage Capital Partners’s Portfolio STAA Stock Details STAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-159,765
Closed -$3.69M – 1068
2025
Q4 		$3.69M Buy
+159,765
New +$4.12M 0.01% 792

Other funds holding STAA

BC
Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
YC
Yunqi Capital Hong Kong $125M AUM 13.99% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AIM
Anatole Investment Management Central, Hong Kong $590M AUM 751.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Adage Capital Partners's STAA Position: Q1 2026 in Review

Adage Capital Partners sold out of STAAR Surgical (STAA) in Q1 2026, closing a stake of 159,765 shares — an estimated $3.69M sold.

Adage Capital Partners first reported a position in STAA in Q4 2025 and held it in 1 quarter. The position peaked at $3.69M in Q4 2025. 187 funds tracked by Wall St. Rank hold STAA as of Q1 2026.

  • Adage Capital Partners reported no remaining STAAR Surgical position as of Q1 2026 after selling out during the quarter.
  • Adage Capital Partners sold 159,765 STAAR Surgical shares in Q1 2026, an estimated $3.69M.
  • Adage Capital Partners first reported a position in STAAR Surgical in Q4 2025 and held it in 1 quarter.
  • Adage Capital Partners's STAAR Surgical position peaked at $3.69M in Q4 2025.
  • 187 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2026.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.